Epidemiological studies have shown a higher incidence of depressive symptoms and suicidal ideation in young men, especially in men under 45, particularly with alopecia symptoms, who take finasteride. The FDA in 2022 added these possible adverse effects: mood disorder and suicidal ideation.
—El Programa de Ana Rosa: March 4, 2025